Clinical Trial Update: Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating three doses of an inactivated COVID-19 vaccine in patients with pulmonary tuberculosis in China; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• inactivated COVID-19 vaccine

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: COVID-19, Pulmonary Tuberculosis | Phase 4 | Status: UNKNOWN